Asymmetric synthesis and enantioselective teratogenicity of 2-n-propyl-4-pentenoic acid (4-en-VPA), an active metabolite of the anticonvulsant drug, valproic acid
- 1 October 1989
- journal article
- research article
- Published by Elsevier in Toxicology Letters
- Vol. 49 (1) , 41-48
- https://doi.org/10.1016/0378-4274(89)90099-4
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Embryotoxic effects of thalidomide derivatives on the non-human primateCallithrix jacchusArchives of Toxicology, 1988
- The enantiomers of the teratogenic thalidomide analogue EM 12Archives of Toxicology, 1988
- Valproic acid-induced neural tube defects: Reduction by folinic acid in the mouseLife Sciences, 1987
- Fetal growth, major malformations, and minor anomalies in infants born to women receiving valproic acidThe Journal of Pediatrics, 1986
- Pharmacologic evaluation of various metabolites and analogs of valproic acid: Teratogenic potencies in miceFundamental and Applied Toxicology, 1986
- Transfer of valproic acid and its main active unsaturated metabolite to the gestational tissue: Correlation with neural tube defect formation in the mouseTeratology, 1986
- Teratogenic valproic acid concentrations: Infusion by implanted minipumps vs conventional injection regimen in the mouseToxicology and Applied Pharmacology, 1985
- A new model for embryotoxicity testing: teratogenicity and pharmacokinetics of valproic acid following constant-rate administration in the mouse using human therapeutic drug and metabolite concentrationsLife Sciences, 1981
- VALPROIC ACID AND ITS METABOLITES - PLACENTAL-TRANSFER, NEONATAL PHARMACOKINETICS, TRANSFER VIA MOTHERS MILK AND CLINICAL STATUS IN NEONATES OF EPILEPTIC MOTHERS1981
- Non-confirmation of thalidomide induced teratogenesis in rats and miceTeratology, 1977